Evidence map›Paper›PMID 39377582›Full record

ArticleAntimicrobial agents and chemotherapy2024

Variability of macrolide-resistant profile in

Kiyoharu Fukushima, Yuki Matsumoto, Yuko Abe, Kazuki Hashimoto, Daisuke Motooka, Seigo Kitada, Haruko Saito, Sho Komukai, Eriko Fukui, Takayuki Niitsu and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Macrolide-resistantJournal of clinical tuberculosis and other mycobacterial diseases · 2026
    Review
  2. Article
  3. Impact of Surgical Intervention in Patients With Macrolide-Resistant Mycobacterium avium Complex Pulmonary Disease: A Multicentre Study.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2026
    Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Kiyoharu Fukushima *Department of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan.ORCID 0000-0002-9767-7899
Yuki Matsumoto *Department of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases (RIMD), Osaka University, Suita, Osaka, Japan.ORCID 0000-0002-2911-308X
Yuko Abe *Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kazuki HashimotoDepartment of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Daisuke MotookaDepartment of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases (RIMD), Osaka University, Suita, Osaka, Japan.
Seigo KitadaKitada Respiratory Clinic, Yao, Osaka, Japan.
Haruko SaitoDepartment of Clinical Laboratory, National Hospital Organization, Osaka Toneyama Medical Centre, Toyonaka, Osaka, Japan.
Sho KomukaiInstitute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan.
Eriko FukuiDepartment of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Takayuki NiitsuDepartment of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Hiroshi NabeshimaLaboratory of Host Defense, World Premier Institute Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Osaka, Japan.
Yasuharu NagahamaLaboratory of Host Defense, World Premier Institute Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Osaka, Japan.
June YamauchiDepartment of Clinical Laboratory, National Hospital Organization, Osaka Toneyama Medical Centre, Toyonaka, Osaka, Japan.
Tadayoshi NittaDepartment of Clinical Laboratory, National Hospital Organization, Osaka Toneyama Medical Centre, Toyonaka, Osaka, Japan.
Takuro NiiDepartment of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan.
Takanori MatsukiDepartment of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan.
Kazuyuki TsujinoDepartment of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan.
Keisuke MikiDepartment of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan.
Yasushi ShintaniDepartment of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Atsushi KumanogohDepartment of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Shizuo AkiraDepartment of Host Defense, Research Institute for Microbial Diseases (RIMD), Osaka University, Suita, Osaka, Japan.
Shota NakamuraDepartment of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases (RIMD), Osaka University, Suita, Osaka, Japan.ORCID 0000-0003-2058-5942
Hiroshi KidaDepartment of Respiratory Medicine, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan.ORCID 0000-0002-9351-7855

Funding

Foundation of Kinoshita Memorial Enterprise (は)GlaxoSmithKline (GSK) A-32Japan Agency for Medical Research and Development (AMED) JP21lm0203007Japan Agency for Medical Research and Development (AMED) JP23fk0108673h0701Japanese Respiratory Society Boehringer Ingelheim Research Grant ProgramJapan Intractable Diseases Research Foundation (JIDRF)MEXT | Japan Society for the Promotion of Science (JSPS) JP21K08194MEXT | Japan Society for the Promotion of Science (JSPS) JP21K16118MEXT | Japan Society for the Promotion of Science (JSPS) JP24K11378MSD Life Science Foundation, Public Interest Incorporated Foundation (MSD Life Science Foundation)Senri Life Science FoundationShionogi (Shionogi & Co. Ltd.)Takeda Science Foundation (TSF)
6 · The paper itself

Abstract

This single-center retrospective study aimed to analyze the variability of macrolide resistance (MR) in 68 patients with

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialMacrolidesMicrobial Sensitivity TestsMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionAgedFemaleHumansLung DiseasesMaleMiddle AgedRetrospective StudiesAnti-Bacterial AgentsMacrolidesdrug resistancemacrolide resistanceMycobacterium avium complexnon-tuberculous mycobacteriavariable number tandem repeatwhole-genome sequence

Identifiers

PMID39377582
PMCPMC11539230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.